GT Biopharma, Inc. GTBP
Set alert
5.21 USD +0.08 +1.56%
As of Nov 3, 10:09 AM ET
5.05 Day range 5.32
4.91 52-week range 28.75
- YTD
- +563.69%
- 1 year
- +736.28%
- Open
- 5.16
- Prev close
- 5.13
- Mkt cap
- 10.74M
- Vol
- 33.59K
- Avg vol
- 64.96K
- EPS
- -147.50
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 5.05
- High
- 5.32
- Forward P/E
- -0.26
- Beta
- 0.57
- Short ratio
- 0.71
- Inst. own
- 67.52%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Apr 4, 2024
- 50-d avg
- 2.76
- 200-d avg
- 3.00
- 1y target
- 11.00
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -12.42M | -14.36M | -13.58M | -21.26M | -57.52M | |
| -28.35M | -13.16M | -7.60M | -20.88M | -58.01M | |
| -167.00 | -174.00 | -141.00 | -492.00 | -1,545.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 6.91M | 4.04M | 1.08M | 5.68M | 8.97M | |
| 8.11M | 4.23M | 14.11M | 16.74M | 32.17M | |
| 2.32M | 5.90M | 6.63M | 5.00M | 10.26M | |
| 5.79M | -1.67M | 7.48M | 11.73M | 21.91M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -12.91M | -12.90M | -8.85M | -15.22M | -15.61M | |
| 15.78M | 2.98M | 6.27M | -224.00K | 42.32M | |
| 2.86M | 2.96M | -4.59M | -3.30M | 3.67M |